218 related articles for article (PubMed ID: 23371961)
1. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.
Nakanishi K; Iijima K; Ishikura K; Hataya H; Nakazato H; Sasaki S; Honda M; Yoshikawa N;
Clin J Am Soc Nephrol; 2013 May; 8(5):756-62. PubMed ID: 23371961
[TBL] [Abstract][Full Text] [Related]
2. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D; Hari P; Sinha A; Pandey S; Bagga A
Clin J Am Soc Nephrol; 2021 Feb; 16(2):225-232. PubMed ID: 33478976
[TBL] [Abstract][Full Text] [Related]
3. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S; Hirano D; Mizutani A; Sakuraya K; Yamada A; Sakurai S; Shimizu T
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[TBL] [Abstract][Full Text] [Related]
4. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
[TBL] [Abstract][Full Text] [Related]
5. Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study.
Dossier C; Delbet JD; Boyer O; Daoud P; Mesples B; Pellegrino B; See H; Benoist G; Chace A; Larakeb A; Hogan J; DeschĂȘnes G
Pediatr Nephrol; 2019 Apr; 34(4):671-678. PubMed ID: 30552564
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
7. Predictors of frequent relapsing and steroid-dependent nephrotic syndrome in children.
Dakshayani B; Lakshmanna M; Premalatha R
Turk Pediatri Ars; 2018 Mar; 53(1):24-30. PubMed ID: 30083071
[TBL] [Abstract][Full Text] [Related]
8. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP; Abhinay A; Mishra RN; Prasad R; Pohl M
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[TBL] [Abstract][Full Text] [Related]
9. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
[TBL] [Abstract][Full Text] [Related]
10. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
11. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T; Nakanishi K; Ishikura K; Ito S; Nakamura H; Sako M; Saito-Oba M; Nozu K; Shima Y; Iijima K; Yoshikawa N;
BMC Nephrol; 2018 Sep; 19(1):223. PubMed ID: 30200895
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M; Sinha A; Khandelwal P; Hari P; Bagga A
Pediatr Nephrol; 2019 May; 34(5):829-835. PubMed ID: 30194663
[TBL] [Abstract][Full Text] [Related]
13. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
Esezobor CI; Ladapo TA; Lesi FE
Niger J Clin Pract; 2016; 19(2):254-8. PubMed ID: 26856291
[TBL] [Abstract][Full Text] [Related]
14. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V; Krishnamurthy S; Harichandrakumar KT
Pediatr Nephrol; 2016 Apr; 31(4):595-604. PubMed ID: 26759000
[TBL] [Abstract][Full Text] [Related]
15. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP; Thakur N; Mishra RN; Prasad R
J Nephrol; 2012; 25(3):394-400. PubMed ID: 21928226
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
Hiraoka M; Tsukahara H; Matsubara K; Tsurusawa M; Takeda N; Haruki S; Hayashi S; Ohta K; Momoi T; Ohshima Y; Suganuma N; Mayumi M;
Am J Kidney Dis; 2003 Jun; 41(6):1155-62. PubMed ID: 12776266
[TBL] [Abstract][Full Text] [Related]
17. [Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Hirano D; Nishizaki N; Kanai H; Hara S; Ohtomo Y; Umino D; Fujinaga S
Nihon Jinzo Gakkai Shi; 2010; 52(8):1029-36. PubMed ID: 21254699
[TBL] [Abstract][Full Text] [Related]
18. Remission and Relapses in Children with Steroid Sensitive Nephrotic Syndrome in Umuahia, South East Nigeria.
Ibeneme CA; Onuh EF; Ezuruike EO
West Afr J Med; 2020 Oct; 37(5):548-554. PubMed ID: 33058131
[TBL] [Abstract][Full Text] [Related]
19. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M; Tsukahara H; Haruki S; Hayashi S; Takeda N; Miyagawa K; Okuhara K; Suehiro F; Ohshima Y; Mayumi M
Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
[TBL] [Abstract][Full Text] [Related]
20. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]